Peak Pharmaceuticals (OTCMKTS:PKPH) Shares Down 55.7% – Here’s What Happened

Peak Pharmaceuticals, Inc. (OTCMKTS:PKPHGet Free Report)’s share price traded down 55.7% during mid-day trading on Monday . The stock traded as low as $2.70 and last traded at $3.00. 3,378 shares traded hands during mid-day trading, a decline of 63% from the average session volume of 9,053 shares. The stock had previously closed at $6.77.

Peak Pharmaceuticals Stock Performance

The business’s 50-day moving average is $3.60 and its 200-day moving average is $2.30.

About Peak Pharmaceuticals

(Get Free Report)

Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.

See Also

Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.